Member Info for robortsmith

1,000 people have joined the lecture - 999 synairgens from lse and 1 keen uni guy

its all about interferons on yes

first uni lecture ive ever been on time to

whos waiting? great music..

think if you said a week ago sp 202, umpteen million in the bank, founder knighted and a clear plan to win this thing I think I would have been happy :)

And twice the profit ;)

where she works:

About
We advise the Prime Minister and members of the Cabinet, to ensure that government policies and decisions are informed by the best scientific evidence and strategic long-term thinking.

We are responsible for:

- giving scientific advice to the Prime Minister and members of the Cabinet, through a programme of projects that reflect the priorities of the Government Chief Scientific Adviser

- ensuring and improving the quality and use of scientific evidence and advice in government (through advice and projects and by creating and supporting connections between officials and the scientific community)

- providing the best scientific advice in the case of emergencies, through the Scientific Advisory Group for Emergencies (SAGE)

- helping the independent Council for Science and Technology provide high level advice to the Prime Minister

this person has liked the professor's preview on linked in out of interest:

Laura (Pleasants) Eden
Deputy Director - Covid strategy and delivery, Government Office for Science

Government Office for Science
Government Administration London, England 371 followers
We ensure that government policies and decisions are informed by the best scientific evidence and strategic thinking

for 80 mil they could get a bigger zoom licence!

https://www.eventbrite.co.uk/e/professor-stephen-holgate-distinguished-lecture-tickets-120496495261?fbclid=IwAR2hYIh4enV6ZoYTRCtGMd1Pu05P2ZpFP6e7j-RLjQOpdI7TR7VB7NCt3Tg

only just watched the preview of tonights lecture not sure if its been mentioned yet.

didnt think he'd actually mention synairgen tonight yet in only 50 seconds of the preview he mentions interferons and synairgen! should be a good one tonight.

preview here:

https://www.youtube.com/watch?v=iwNbvoD9hTY

Director Dealing/PDMR Announcement



Further to the announcement earlier today regarding the Placing, the Company makes the below announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014) in respect of the exercise of options by Richard Marsden, CEO of the Company, and John Ward, Finance Director of the Company.



Enquiries:

Synairgen plc +44 (0) 23 8051 2800

Richard Marsden (Chief Executive Officer)

John Ward (Finance Director)

finnCap - Nominated Adviser and Joint Bookrunner +44 (0) 20 7220 0500

Geoff Nash / James Thompson / Charlie Beeson (Corporate Finance)

Alice Lane / Sunila de Silva (ECM)

Numis - Joint Bookrunner +44 (0) 20 7260 1000

James Black / Freddie Barnfield / Duncan Monteith

Consilium Strategic Communications - Financial Media and Investor +44 (0) 20 3709 5700

Relations Adviser

Mary-Jane Elliott / Sue Stuart / Olivia Manser





About Synairgen

Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on lung viral defence in asthma, COPD and COVID-19, uses its differentiating human biology BioBank platform and world-renowned international academic KOL network to discover and develop novel therapies for respiratory disease. Synairgen is quoted on AIM (LSE: SNG). For more information about Synairgen, please see www.synairgen.com





1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

Richard Marsden

2.

Reason for notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Synairgen plc

b)

LEI

213800IMMTOPPDF8HD24

4.

Details of the transaction(s):

a)

Description of the financial instrument

Identification code

Options over ordinary shares of 1p each

GB00B0381Z20

b)

Nature of the transaction

Exercise of options over Ordinary Shares



c)

Price(s) and volume(s)

386,842 Ordinary shares of 1p each

d)

Aggregated information

Aggregated volume Price

n/a

e)

Date of the transaction

15 October 2020

f)

Place of the transaction

London Stock Exchange



1.

Details of Persons Discharging Managerial Responsibilities ('PDMR') / person closely associated with them ('PCA')

a)

Name

John Ward

2.

Reason for notification

a)

Position / status

Finance Director

b)

Initial notification / ame

does it mean anything?

thanks all makes sense - is one of the countries usa do we know?

why is the trial being split over 20 countries out of interest? seems complicated although will hopefully lead to at least those 20 countries wanting sng afterwards! sorry if already answered its difficult to read everything at the mo!

There’s only one proved treatment and thats us

https://www.bbc.co.uk/news/health-54540544

Those who have not just joined us to Deramp will know the 15th has always been identified as the start of a lot of news for Synairgen. Will be a rollercoaster day but expect some surprises . Holding all the way

i set some stop losses earlier but now have cancelled them. i didnt panic when it fell to 34, i didnt panic a week ago when it was under 150. if it goes to 175 so be it i'm not trading this i'm being patient - as RM said - and in it all the way.

i may still spend a lot of time on the toilet tomorrow though

i hope sir prof is well versed in placings for all the questions he will get after his lecture tomorrow!

that is a v big point that has been lost in the enormity of the rns

i presume stop losses wont work tomorrow and its a case of riding out the short term pain?